Angiotensin II-Mediated Adaptive and Maladaptive Remodeling of Cardiomyocyte Excitation-Contraction Coupling

Circulation Research

Volumn 105, Issue 1, 2009, Pages 42-50

  Gusev, Konstantin ^a   Domenighetti, Andrea A ^b,d   Delbridge, Lea M D ^c   Pedrazzini, Thierry ^b   Niggli, Ernst ^a   Egger, Marcel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Angiotensin II; Calcium exchange; Cardiac excitation; Contraction coupling; Hypertrophy; Remodeling; Sodium

Indexed keywords

ANGIOTENSIN II; CALCIUM ION; ANGIOTENSINOGEN; CALCIUM; SODIUM CALCIUM EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONTROLLED STUDY; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; HEART CONTRACTION; HEART EXCITATION; HEART HEMODYNAMICS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHOTOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; SODIUM CALCIUM EXCHANGE; ANIMAL; CARDIOMEGALY; GENETICS; HEART FUNCTION TEST; HEART MUSCLE CELL; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; CALCIUM; CARDIOMEGALY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; SODIUM-CALCIUM EXCHANGER;

EID: 67949100573     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.189779     Document Type: Article

References (41)

1. Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature. 2008;451:919-928.
2. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
3. Yamazaki T, Komuro I, Yazaki Y. Role of the renin-angiotensin system in cardiac hypertrophy. Am J Cardiol. 1999;83:53H-57H.
4. Domenighetti AA, Wang Q, Egger M, Richards SM, Pedrazzini T, Delbridge LM. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension. 2005;46:426-432.
5. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res. 1993;73: 413-423.
6. Pellieux C, Sauthier T, Aubert JF, Brunner HR, Pedrazzini T. Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice. J Hypertens. 2000;18:1307-1317.
7. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-C97.
8. Mazzolai L, Nussberger J, Aubert JF, Brunner DB, Gabbiani G, Brunner HR, Pedrazzini T. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension. 1998;31:1324-1330.
9. Chen-Izu Y, Chen L, Banyasz T, McCulle SL, Norton B, Scharf SM, Agarwal A, Patwardhan A, Izu LT, Balke CW. Hypertension-induced remodeling of cardiac excitation-contraction coupling in ventricular myocytes occurs prior to hypertrophy development. Am J Physiol Heart Circ Physiol. 2007;293:H3301-H3310.
10. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
11. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitationcontraction coupling in experimental cardiac hypertrophy and heart failure. Science. 1997;276:800-806.
12. 2+ exchanger in reverse remodeling: relevance for LVAD-recovery. Ann N Y Acad Sci. 2007; 1099:349-360.
13. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res. 1999;85:1009-1019.
14. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure. I. Experimental studies. Circ Res. 1999;84:562-570. (Pubitemid 29138593)
15. 2+ uptake and release mechanisms. Am J Physiol Heart Circ Physiol. 2007;292:H1607-H1618.
16. 2+ exchanger in the failing heart. Circ Res. 2000;87:641-643.
17. Domenighetti AA, Boixel C, Cefai D, Abriel H, Pedrazzini T. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J Mol Cell Cardiol. 2007;42:63-70.
18. Cerbai E, Sartiani L, De Paoli P, Mugelli A. Isolated cardiac cells for electropharmacological studies. Pharmacol Res. 2000;42:1-8.
19. 2+ exchanger by extracellular protons in guinea-pig ventricular myocytes. J Physiol. 2000; 523:353-366.
20. Urbanczyk J, Chernysh O, Condrescu M, Reeves JP. Sodium-calcium exchange does not require allosteric calcium activation at high cytosolic sodium concentrations. J Physiol. 2006;575:693-705.
21. Seidler T, Hasenfuss G, Maier LS. Targeting altered calcium physiology in the heart: translational approaches to excitation, contraction, and transcription. Physiology. 2007;22:328-334.
22. Allen IS, Cohen NM, Dhallan RS, Gaa ST, Lederer WJ, Rogers TB. Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: insights into the underlying biochemical mechanisms. Circ Res. 1988;62:524-534.
23. Sjaastad I, Wasserstrom JA, Sejersted OM. Heart failure-a challenge to our current concepts of excitation-contraction coupling. J Physiol. 2003; 546:33-47.
24. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol. 2002;34:951-969.
25. Clement S, Pellieux C, Chaponnier C, Pedrazzini T, Gabbiani G. Angiotensin II stimulates alpha-skeletal actin expression in cadiomyocytes in vitro and in vivo in the absence of hypertension. Differentiation. 2001; 69:66-74.
26. 2+ release in cardiac myocytes. Circ Res. 2002;91:414-420.
27. Basso N, Cini R, Pietrelli A, Ferder L, Terragno NA, Inserra F. Protective effect of long-term angiotensin II inhibition. Am J Physiol Heart Circ Physiol. 2007;293:H1351-H1358.
28. Gyorke S, Terentyev D. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease. Cardiovasc Res. 2008;77:245-255.
29. 2+ exchange during cardiac hypertrophy after myocardial infarction. Circ Res. 2002;91:323-330.
30. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell. 2000;101:365-376.
31. Bridge JHB, Savio-Galimberti E. What are the consequences of phosphorylation and hyperphosphorylation of ryanodine receptors in normal and failing heart? Circ Res. 2008;10:e65-e67.
32. 2+ leak in chronic heart failure. Circ Res. 2008;103: U1466-U1252.
33. 2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2009;104: 201-209.
34. Aksnes TA, Flaa A, Strand A, Kjeldsen SE. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure. J Hypertens. 2007;25: 15-23.
35. Lorell BH, Carabello BA. Left ventricular hypertrophy. Pathogenesis, detection, and prognosis. Circulation. 2000;102:470-479.
36. Mazzolai L, Pedrazzini T, Nicoud F, Gabbiani G, Brunner HR, Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension. 2000;35: 985-991.
37. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW. Transgenic G alpha q overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A. 1997;94:8121-8126.
38. Dorn GW, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest. 2005;115:527-537.
39. De Mello WC, Danser AH. Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension. 2000;35:1183-1188.
40. Harrap SB, Dominiczak AF, Fraser R, Lever AF, Morton JJ, Foy CJ, Watt GCM. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation. 1996;93: 1148-1154.
41. 2+ . J Physiol. 1989;414:499-520.